Woodline Partners LP Arbutus Biopharma Corp Transaction History
Woodline Partners LP
- $9.97 Billion
- Q2 2024
A detailed history of Woodline Partners LP transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Woodline Partners LP holds 926,534 shares of ABUS stock, worth $3.57 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
926,534
Previous 4,070,659
77.24%
Holding current value
$3.57 Million
Previous $10.5 Million
72.75%
% of portfolio
0.03%
Previous 0.1%
Shares
9 transactions
Others Institutions Holding ABUS
# of Institutions
137Shares Held
95.4MCall Options Held
3.44MPut Options Held
377K-
Morgan Stanley New York, NY21MShares$80.7 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$49.5 Million30.08% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$44.5 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.57MShares$33 Million10.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.02MShares$27 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $577M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...